Zillow, Revance Therapeutics, Albertsons and more – .

0
24
Zillow, Revance Therapeutics, Albertsons and more – .


Take a look at some of the biggest drivers in the premarket:
Zillow (Z) – Zillow slipped 6.4% in pre-market trading, following a Bloomberg report that the company temporarily halted its home buying service due to overwhelming demand.

Revance Therapeutics (RVNC) – Shares of Revance plunged 33.2% in pre-market after the Food and Drug Administration refused to approve an injectable treatment for facial wrinkles, noting gaps in the wake of the FDA inspection of manufacturing facilities. The company said no other concerns were raised in the FDA’s response. The treatment is considered a possible competitor to the top selling Botox treatment.

Walt Disney (DIS) – Disney lost 1.8% in pre-release after Barclays downgraded the title on a ‘par weight’ to ‘overweight’, citing concerns over a significant slowdown in the growth of the streaming service Disney + .

Albertsons (ACI) – The supermarket operator gained 64 cents per share for its most recent quarter, beating the consensus estimate of 45 cents per share. Income also exceeded Wall Street forecasts. Albertsons increased its quarterly dividend from 20% to 12 cents per share. Its shares jumped 3.6% in pre-market.

Netflix (NFLX) – Netflix estimates the value of its hit series “Squid Game” at nearly $ 900 million, according to an internal document seen by Bloomberg. The series only cost $ 21.4 million to produce.

Philips (PHG) – Philips reported lower than expected sales for the third quarter, and the Dutch medical technology company lowered its full-year sales and profit outlook. Philips is hit hard by a respirator recall and a global shortage of electronic components. Its shares fell 2.1% in the pre-market.

Stellantis (STLA) – Stellantis is forming a joint venture with South Korean battery maker LG Energy Solution to produce batteries and components for the North American market. The batteries will be produced at the automaker’s factories in the United States, Canada and Mexico. Stellantis shares slipped 1% in pre-market trading.

Goldman Sachs (GS) – Goldman has received approval from Chinese regulators to take full ownership of a local securities unit. Goldman has not disclosed how much he paid for the 49% he did not own in the business he has co-owned since 2004.

Biogen (BIIB) – The drugmaker said a late-stage trial of an investigational treatment for ALS failed to meet its primary goal, but noted favorable trends in other measures of progress towards the treatment of the fatal disease. Its shares lost 1% in the pre-market share.

Southwest Airlines (LUV) – Southwest has asked a federal court to dismiss an effort by its pilots to prevent the airline from applying a Covid vaccine warrant. The pilots’ union said Southwest unilaterally changed the work rules without negotiating first.

NetApp (NTAP) – NetApp has been demoted to “sell” from “neutral” to Goldman Sachs, which cites the 2022 IT spending environment. It also lowered its price target for the cloud computing company’s shares to 81 $ per share versus $ 85. NetApp shares fell 2.2% in pre-market trading.

LEAVE A REPLY

Please enter your comment!
Please enter your name here